John Sullivan, MD
Gynecology · Cincinnati, OHNPI 1053340372
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,457 of the $3,936 with a category attached, or 62.4%. 24 manufacturers reported payments, led by Boston Scientific at 53.9% of the total. Reporting peaked in 2019 at $2,671 and has fallen 88.5% since, to $307 in 2025.
Across 130 payments — averaging $30.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$659
- Astellas Pharma US Inc$227
- Distalmotion US$160
- Therapeuticsmd, Inc.$143
- Optumhealth Care Solutions, LLC$97
- plus $528 from 18 others
What the payments were for
- Travel & lodging$1,43636%
- Food & beverage$2,45762%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $2,122 |
| AbbVie(2 entities) | 53 | $659 |
| Astellas Pharma US Inc | 11 | $227 |
| Distalmotion US | 1 | $160 |
| Therapeuticsmd, Inc. | 8 | $143 |
| Optumhealth Care Solutions, LLC | 5 | $97 |
| Ferring Pharmaceuticals Inc. | 4 | $63 |
| Hologic Sales And Service, LLC | 5 | $62 |
| Merck | 4 | $53 |
| AMAG Pharmaceuticals, Inc. | 3 | $43 |
| Duchesnay USA Incorporated | 3 | $39 |
| Exeltis, USA Inc. | 2 | $39 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Mayne Pharma Commercial LLC | 3 | $30 |
| Amgen | 2 | $26 |
| Lupin Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $22 |
| Organon | 1 | $16 |
| Bayer | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Celltrion USA Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Minerva Surgical, Inc | 1 | $12 |
| Meditrina | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS$1,135
- GENERAL BPH$822
- DEXTER L6 ROBOT$160
- Orilissa$115
How this compares
$3,936 in reported general payments places this provider in the 75th percentile of 77 gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 73 | $2,919 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $312 |
| Alendronate Sodium | 40 | $135 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Cincinnati
- Derek VanamerongenCincinnati$316K
- Joseph FranzeseCincinnati$18K
- Marianna VardakaCincinnati$8K
- Sarah BartlettCincinnati$2K
- Jon FacklerCincinnati$2K
- Linda EvansCincinnati$1K
- Jennifer ThieCincinnati$1K
- Scott FiresteinCincinnati$1K
- Molly KatzCincinnati$569
- Kenneth PalmerCincinnati$439
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.